Org.nr 985 012 059 2021 → 2022 Year-over-year analysis

NAVAMEDIC ASA: årsregnskap 2022 vs 2021

Returned to profit, fresh owner capital

approved 2023-06-01; registry 2023-08-10; journal 2023 664013

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2022 with 2021 for NAVAMEDIC ASA. Revenue 45.26m NOK → 46.25m NOK (+2.2%). Net result -3.28m NOK → +40.97m NOK. Equity 145.7k NOK → 212.8k NOK.

On the constructive side: revenue rose; turned profitable; equity strengthened. Pressures included: operating result weakened.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for NAVAMEDIC ASA.

Scorecard

Revenue
45.26m NOK 46.25m NOK
+2.2%
Operating result
-6.77m NOK -9.74m NOK
-43.8%
Net result
-3.28m NOK +40.97m NOK
+1348.0%
Equity
145.7k NOK 212.8k NOK
+46.0%
Cash
2.77m NOK 6.01m NOK
+117.3%
Total assets
216.64m NOK 297.70m NOK
+37.4%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 45.26m NOK to 46.25m NOK (+2.2% YoY). Calculated

  • ↑

    Turned profitable

    Net result flipped from a loss of 3.28m NOK to a profit of 40.97m NOK. Calculated

  • ↑

    Equity strengthened

    Book equity 145.7k NOK → 212.8k NOK (equity ratio 0.1% → 0.1%). Calculated

  • ↑

    Cash rose

    Bank deposits 2.77m NOK → 6.01m NOK (+117.3% YoY). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 177.9k NOK → 203.16m NOK (+202.98m NOK). Reported fact

What deteriorated

  • ↓

    Operating result weakened

    Operating result -6.77m NOK → -9.74m NOK (op. margin -15.0% → -21.0%). Calculated

Things to notice

  • ·

    Book investments changed

    Investment / intangible book value 129.61m NOK → 1 NOK. Reported fact